SW · MED.SW
Medartis Holding AG
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Basel 4057
- Website
- medartis.com
Price · as of 2024-12-31
$76.90
Market cap 1.12B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $67.37 | -12.39% |
| Intrinsic Value(DCF) | $29.44 | -61.72% |
| Graham-Dodd Method(GD) | $20.17 | -73.77% |
| Graham Formula(GF) | $3.95 | -94.86% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | $2.87 | $5.64 | |||
| 2017 | $1.51 | $1.56 | |||
| 2018 | $59.50 | $113.98 | $15.71 | $22.20 | $9.11 |
| 2019 | $44.90 | $54.45 | $2.50 | $19.00 | $2.75 |
| 2020 | $56.50 | $61.44 | $0.00 | $17.48 | $0.00 |
| 2021 | $144.40 | $155.42 | $3.47 | $21.66 | $18.68 |
| 2022 | $69.70 | $214.76 | $1.70 | $14.39 | $0.00 |
| 2023 | $72.30 | $740.63 | $21.34 | $18.21 | $1.19 |
| 2024 | $71.60 | $67.37 | $1.17 | $20.17 | $3.95 |
AI valuation
Our deep-learning model estimates Medartis Holding AG's (MED.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $67.37
- Current price
- $76.90
- AI upside
- -12.39%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$29.44
-61.72% upside
Graham-Dodd
$20.17
-73.77% upside
Graham Formula
$3.95
-94.86% upside
About Medartis Holding AG
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
- CEO
- Matthias Schupp
- Employees
- 816
- Beta
- 1.27
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($29.44 ÷ $76.90) − 1 = -61.72% (DCF, example).